Molbio Diagnostics, a Goa-based POC diagnostics company, filed its DRHP to raise Rs 200 crore via fresh issue and 1.25 crore shares through OFS. Its patented ‘Truenat’ PCR platform enables rapid decentralized testing. FY25 revenue stood at Rs 1,020 crore, PAT Rs 138.5 crore. Promoters include Sriram family and Exxora Trading.
South Korea’s KOSPI drops 7% as global chipmaker selloff deepens
South Korean stocks experienced a significant decline on Tuesday. This downturn was driven by a global selloff in chipmakers and rising competition from China. SK